Skip to main content
All lobbying filings

Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q2 report for Moderna US Inc. on July 16, 2026, reporting $80,000 in lobbying income.

Lobbying for Moderna US Inc. · Pharmaceuticals

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for MODERNA US INC.

All filings by Brownstein Hyatt Farber Schreck, LLP · Everything Moderna US Inc. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 16, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain n

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem